SGHT · Sight Sciences, Inc. · Documents

Aug 1

Current report 8-K

Financial results, Regulation FD disclosure

Jun 7

Current report 8-K Events of Jun 6

Shareholder vote results

May 30

Current report 8-K

Other events

May 6

Quarterly report 10-Q FY2024 Q1, ended Mar 31

Quarterly report for FY2024 Q1

Revenue $19.27M ▲ 2.3% Net loss $16.27M Diluted EPS -$0.33

May 2

Current report 8-K

Completed an acquisition or sale of assets, Regulation FD disclosure

Apr 29

Current report 8-K Events of Apr 26

Other events

Apr 26

Proxy statement DEF 14A Meeting Jun 6, 2024

Proxy statement

Apr 26

Proxy statement DEFA14A

Proxy statement

Mar 31

Earnings call

Q1 2024 earnings call

Mar 13

Annual report 10-K FY2023, ended Dec 31

Annual report for FY2023

Revenue $81.06M ▲ 13.6% Net loss $55.55M Diluted EPS -$1.14

Mar 7

Earnings call

Q4 2023 earnings call

Mar 7

Current report 8-K

Financial results, Regulation FD disclosure

Feb 2

Current report 8-K Events of Jan 30

Director or officer change, or executive pay

Jan 23

Current report 8-K Events of Jan 22

Entered into a material agreement, Ended a material agreement, New debt or off-balance-sheet obligation, Unregistered sale of equity, Regulation FD disclosure

Dec 18

Current report 8-K Events of Dec 15

Entered into a material agreement

Dec 7

Current report 8-K

Other events

Nov 9

Current report 8-K

Other events

Nov 7

Earnings call

Q3 2023 earnings call

Nov 7

Current report 8-K

Financial results, Regulation FD disclosure

Nov 7

Quarterly report 10-Q FY2023 Q3, ended Sep 30

Quarterly report for FY2023 Q3

Revenue $20.01M ▲ 7.1% Net loss $13.04M Diluted EPS -$0.27

Oct 26

Current report 8-K

Regulation FD disclosure, Other events

Oct 17

Current report 8-K

Exit or restructuring costs, Regulation FD disclosure

Sep 20

Current report 8-K

Regulation FD disclosure

Sep 11

Current report 8-K

Director or officer change, or executive pay, Regulation FD disclosure

Aug 7

Quarterly report 10-Q FY2023 Q2, ended Jun 30

Quarterly report for FY2023 Q2

Revenue $23.47M ▲ 36.2% Net loss $14.75M Diluted EPS -$0.30

Aug 3

Earnings call

Q2 2023 earnings call

Aug 3

Current report 8-K

Financial results, Regulation FD disclosure

Jun 12

Current report 8-K Events of Jun 8

Shareholder vote results

Jun 9

Current report 8-K Events of Jun 8

Regulation FD disclosure, Other events

Jun 2

Current report 8-K

Regulation FD disclosure, Other events

May 22

Registration statement S-3/A

Registration statement

May 8

Current report 8-K

Regulation FD disclosure

May 8

Quarterly report 10-Q FY2023 Q1, ended Mar 31

Quarterly report for FY2023 Q1

Revenue $18.82M ▲ 26.5% Net loss $17.07M Diluted EPS -$0.35

May 4

Earnings call

Q1 2023 earnings call

May 4

Current report 8-K

Financial results

Apr 26

Proxy statement DEF 14A Meeting Jun 8, 2023

Proxy statement

Apr 26

Proxy statement DEFA14A

Proxy statement

Apr 3

Current report 8-K

Director or officer change, or executive pay, Regulation FD disclosure

Mar 16

Annual report 10-K FY2022, ended Dec 31

Annual report for FY2022

Revenue $71.33M ▲ 45.7% Net loss $86.24M Diluted EPS -$1.80

Mar 16

Registration statement S-3

Registration statement

Mar 13

Current report 8-K

Financial results

Jan 9

Earnings call

Q4 2022 earnings call

Jan 9

Current report 8-K Events of Jan 5

Financial results, Director or officer change, or executive pay, Regulation FD disclosure

Nov 10

Earnings call

Q3 2022 earnings call

Nov 10

Current report 8-K

Financial results

Nov 10

Quarterly report 10-Q FY2022 Q3, ended Sep 30

Quarterly report for FY2022 Q3

Revenue $18.68M ▲ 42.6% Net loss $22.23M Diluted EPS -$0.46

Aug 23

Current report 8-K

Regulation FD disclosure

Aug 11

Earnings call

Q2 2022 earnings call

Aug 11

Current report 8-K

Financial results

Aug 11

Quarterly report 10-Q FY2022 Q2, ended Jun 30

Quarterly report for FY2022 Q2

Revenue $17.23M ▲ 37.4% Net loss $23.84M